Elite in Autoimmune Hemolytic Anemia

Guy G. Leverger

Paris, FR 
Elite in Autoimmune Hemolytic Anemia
Paris, FR 
OverviewLocationsClinical Research

Overview

Guy Leverger practices in Paris, France. Mr. Leverger is rated as an Elite expert by MediFind in the treatment of Autoimmune Hemolytic Anemia. His top areas of expertise are Evans Syndrome, Autoimmune Hemolytic Anemia, Childhood Acute Myeloid Leukemia, Splenectomy, and Bone Marrow Transplant.

His clinical research consists of co-authoring 165 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 15 articles in the study of Autoimmune Hemolytic Anemia.

Gender
Male

Locations

Paris, France
Other Locations
Lille, France
Saint-jean-saint-germain, France
Marseille, France
Saint-etienne-de-valoux, 75012, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Pan-genome Analysis of Neuroblastoma by Comparative Genomic Hybridization and Correlation With Pathology for the Diagnostic and the Prognostic Classification
Pan-genome Analysis of Neuroblastoma by Comparative Genomic Hybridization and Correlation With Pathology for the Diagnostic and the Prognostic Classification
Enrollment Status: Completed
Publish Date: December 01, 2023
Intervention Type: Procedure
Study Phase: Not Applicable
International Randomized Phase II Trial of the Combination of Vincristine and Irinotecan With or Without Temozolomide (VI or VIT) in Children and Adults With Refractory or Relapsed Rhabdomyosarcoma
International Randomized Phase II Trial of the Combination of Vincristine and Irinotecan With or Without Temozolomide (VI or VIT) in Children and Adults With Refractory or Relapsed Rhabdomyosarcoma
Enrollment Status: Completed
Publish Date: September 18, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

165 Total Publications

Azathioprine or mycophenolate mofetil for pediatric autoimmune cytopenia: A propensity score-matched study.
Azathioprine or mycophenolate mofetil for pediatric autoimmune cytopenia: A propensity score-matched study.
Journal: Blood advances
Published: June 20, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Leverger's expertise for a condition
ConditionClose
View All 8 Distinguished Conditions
View All 9 Advanced Conditions
View All 39 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile